KKR Hawaii Expands Equity‑Swap Stake in Henry Schein, Betting on Future Upside While Managing Risk

KKR Hawaii Aggregator L.P. Expands Equity Swap Position at Henry Schein

The latest filing on March 6, 2026 shows KKR Hawaii Aggregator L.P. (KHA) taking a sizable equity‑swap position in Henry Schein Inc. The company has agreed to a total‑return swap covering 918,723 shares at a notional price of $80.55 per share. This is a continuation of KHA’s aggressive “buy” stance that began with a 1.87‑million‑share swap in August 2025 and a smaller 57,348‑share swap in June 2025. The new swap, executed just after the stock closed near $76.27, gives KHA the right to acquire the shares if the swap is exercised, effectively increasing its potential exposure to Henry Schein’s future upside while limiting downside risk through the swap structure.

Implications for Investors and the Company’s Outlook

For investors, the timing of the swap is notable. Henry Schein’s shares have recently trended lower—down 4.9 % in the week and 4.8 % in the month—yet the company remains solidly positioned with a 52‑week high of $89.29 and a strong valuation multiple (P/E ≈ 24.7). KHA’s commitment signals confidence in the company’s long‑term growth prospects, especially given its diversified product portfolio across dental and medical markets. The swap’s notional price of $80.55 sits comfortably below the 52‑week high and near the current trading price, suggesting a bullish view that the stock could rebound. In practice, KHA can lock in exposure without paying the full market price, a strategy that may be attractive to other institutional investors looking for a lower‑cost entry point.

KKR Hawaii Aggregator L.P. – A Transaction Profile

KKR Hawaii Aggregator L.P. is an investment vehicle tied to the broader KKR Group, a global alternative‑investment firm known for leveraged buyouts and structured credit. Historically, KHA has employed equity swaps and other derivative instruments to gain exposure to public companies while managing liquidity and risk. Its pattern at Henry Schein—starting with a large swap in August 2025, a modest one in June 2025, and now a medium‑sized swap in March 2026—shows a measured, phased approach: “buy‑in” the company over time, rather than a single large purchase. This strategy allows KHA to gauge the stock’s performance and adjust its position if the market moves against expectations.

Broader Insider Activity at Henry Schein

The March 6 filing also reveals a flurry of insider trades from senior executives. The SVP‑CFO, South Ronald N., and the SVP‑HR, Christine Zayac, each added substantial positions, while the EVP of Strategic Operations, Mark E., executed a mix of buys and sells, indicating active portfolio management at the executive level. The CEO’s stock option exercise (177,116 options) and other large buys underscore a strong management alignment with shareholders. These moves, combined with KHA’s swap, suggest that both insiders and significant institutional investors see value in Henry Schein’s long‑term trajectory.

What This Means Going Forward

Overall, the data paint a picture of confidence from both insiders and a seasoned investment partner. For investors, the story is one of a company with a stable business model, modest short‑term volatility, and an institutional bet that the stock will rebound toward its 52‑week high. The use of equity swaps by KHA demonstrates sophisticated risk management and could be a sign that Henry Schein’s stock is poised for a gradual upward swing—especially if the company continues to expand its dental and medical product lines and capitalizes on the broader healthcare services trend. As always, potential investors should weigh the company’s fundamentals, market conditions, and the inherent risks of derivative exposure before committing capital.